Inhibikase Therapeutics I... (IKT)
NASDAQ: IKT
· Real-Time Price · USD
1.77
-0.17 (-8.76%)
At close: Jun 17, 2025, 3:27 PM
Inhibikase Therapeutics Revenue
Inhibikase Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending March 31, 2025, Inhibikase Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
15
Market Cap
131.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|